372 related articles for article (PubMed ID: 2821575)
1. Gestational trophoblastic neoplasia: diagnosis with Doppler US.
Taylor KJ; Schwartz PE; Kohorn EI
Radiology; 1987 Nov; 165(2):445-8. PubMed ID: 2821575
[TBL] [Abstract][Full Text] [Related]
2. New criteria for the diagnosis of gestational trophoblastic disease.
Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Feb; 48(2):139-47. PubMed ID: 8381374
[TBL] [Abstract][Full Text] [Related]
4. Pelvic MR imaging findings in gestational trophoblastic disease, incomplete abortion, and ectopic pregnancy: are they specific?
Barton JW; McCarthy SM; Kohorn EI; Scoutt LM; Lange RC
Radiology; 1993 Jan; 186(1):163-8. PubMed ID: 7677973
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
6. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
7. Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia.
Rodriguez GC; Hughes CL; Soper JT; Berchuck A; Clarke-Pearson DL; Hammond CB
Obstet Gynecol; 1994 Nov; 84(5):794-7. PubMed ID: 7936514
[TBL] [Abstract][Full Text] [Related]
8. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
10. Natural history of partial molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
[TBL] [Abstract][Full Text] [Related]
11. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
13. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia.
Messerli ML; Parmley T; Woodruff JD; Lilienfeld AM; Bevilacqua L; Rosenshein NB
Obstet Gynecol; 1987 Apr; 69(4):622-6. PubMed ID: 3029643
[TBL] [Abstract][Full Text] [Related]
14. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
17. Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging.
Kohorn EI; McCarthy SM; Taylor KJ
J Reprod Med; 1998 Jan; 43(1):14-20. PubMed ID: 9475144
[TBL] [Abstract][Full Text] [Related]
18. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
Boots LR; Hatch KD; Younger JB
Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
[No Abstract] [Full Text] [Related]
19. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
[TBL] [Abstract][Full Text] [Related]
20. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
